Overview
Lobbying Costs
75,000€
Financial year: Jan 2019 - Dec 2019
Lobbyists (Full time equivalent)
0.5 Fte (2)
Lobbyists with EP accreditation
2
High-level Commission meetings
1
Lobbying Costs over the years
-
Info
Fresenius Kabi Deutschland GmbH
EU Transparency Register
130305227617-65 First registered on 29 Jun 2017
Goals / Remit
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients. In Europe, Fresenius Kabi is the market leader in infusion therapy and clinical nutrition
Fresenius Kabi employs about 39,000 people worldwide. With our corporate philosophy "caring for life", we are committed to putting essential medicines and technologies in the hands of people who help patients and finding the best answers to the challenges they face. Further we are committed to improving patients' quality of life wherever needed: whether in hospitals, medical centres or at patient's homes.
Fresenius Kabi AG is a wholly owned subsidiary of the Fresenius SE & Co. KGaA healthcare group.Main EU files targeted
Public Health, Industrial and IP Policies, Pricing and Reimbursement Policies, Pharmaceutical and Biosimilars legislation, EU Trade Policy, European external trade agenda, Pharmaceuticals in the environment, global health.
Address
Head Office
Fresenius Kabi Deutschland GmbH
Else-Kröner-Str. 1
Bad Homburg 61352
GERMANY -
People
Total lobbyists declared
2
Employment time Lobbyists 25% 2 Lobbyists (Full time equivalent)
0.5
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
2 accreditations were / are live (in bold) for the selected state of 22 Jun 2020
Name Start date End Date Mr Matthew TURNER 11 Feb 2023 11 Feb 2024 Mr Stefan KOLB 20 Jan 2023 20 Jan 2024 Mr Hrishikesh KULKARNI 24 Mar 2022 24 Mar 2023 Mr Matthew TURNER 05 Nov 2019 31 Oct 2020 Mr Stefan KOLB 10 Oct 2019 01 Nov 2020 Mr David M JAUCH 23 Oct 2018 23 Oct 2019 Complementary Information
Other persons are involved, but less than 25%.
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Companies & groups
-
Networking
Affiliation
Medicines for Europe, Medical Nutrition International
Member organisations
None declared
-
Financial Data
Closed financial year
Jan 2019 - Dec 2019
Lobbying costs for closed financial year
75,000€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
None
Communication activities
None
Other activities
Fresenius Kabi is cooperating with the institutions of the European Union to support policies that improves patient access to affordable medicines.
- Meetings
Meetings
1 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
-
Date 16 Jun 2021 Location online Subject Supply chains for medicines Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Maria Luisa Llano Cardenal (Cabinet member)
- Margaritis Schinas (Vice-President)
Other Lobbyists - Phamaceutical Group of the European Union
- European Federation of Pharmaceutical Industries and Associations
- Novo Nordisk A/S
- Leuphana Universität Lüneburg
- MEDICINES FOR EUROPE
- The European Association of Hospital Pharmacists
- SANOFI
- Bureau Européen des Unions de Consommateurs
- Teva Pharmaceuticals Europe BV
- Pfizer Inc.
- European Chemical Industry Council
- European Patients' Forum (EPF)
- Medichem, S.A.
- European Healthcare Distribution Association
- Meetings